Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 8, 2017
Imaging of primary liver tumors with positron-emission tomographyAlexander R Haug
Cancers|August 12, 2022
Clinical Applications of PSMA PET Examination in Patients with Prostate CancerSazan Rasul, Alexander R Haug
Orbit (Amsterdam, Netherlands)|September 30, 2014
Ga-68-DOTA-TATE PET/CT for discrimination of tumors of the optic pathwayAnnemarie Klingenstein, Alexander R Haug, Christina Miller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 21, 2014
The role of SPECT/CT in radioembolization of liver tumoursHojjat Ahmadzadehfar, Heying Duan, Alexander R Haug, et al.
European Radiology|March 16, 2006
Whole-body MRI and PET-CT in the management of cancer patientsGerwin P Schmidt, Alexander R Haug, Stefan O Schoenberg, et al.
Melanoma Research|October 5, 2010
Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanomaAnnemarie Klingenstein, Alexander R Haug, Martin M Nentwich, et al.
Clinical Nuclear Medicine|July 1, 2020
Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate CancerSandra Barna, Alexander R Haug, Markus Hartenbach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 11, 2011
18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheresAlexander R Haug, Volker Heinemann, Christiane J Bruns, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
[Selective intraarterial radiotherapy (SIRT) of malignant liver tumors]Stefan P Müller, Samer Ezziddin, Gerald Antoch, et al.
Pageof 9